Microbes
Microbes is multidisciplinary international, open access, peer reviewed scientific journal committed to publish original research, critical reviews, and short communications, reporting theoretical, experimental, applied, and descriptive work in all aspects of microbial science.
Managing Editor: Dr. Sajjad Hyder
Country of Publication: Pakistan
Format: Print & Online
Frequency: 03
Publication Dates: April, August, December
Language: English
Author Fees: Yes
Types of Journal: Academic/Scholarly Journal
Access: Open Access
Indexed & Abstracted: Yes
Policy: Double blind peer-reviewed
Review Time: 04-06 weeks approximately
Contact & Submission e-mail: microbes@esciencepress.net
Alternate e-mail: info@esciencepress.net
Journal Scope
The journal aims to serve the research community by providing a platform for researchers to publish quality research in both fundamental and applied microbiology. The journal considers submissions on microbes infecting or interacting with microbes, plants, animals, and humans covering the following aspects:
Agricultural microbiology
Beneficial microbes
computational, systems, & synthetic microbiology
Environmental microbiology
Food microbiology
Industrial microbiology
Medical & pharmaceutical microbiology
Microbial physiology & ecology
Microbial biochemistry
Microbial genetics & genomics
Microbial biotechnology
veterinary microbiology
Microbes follow guidelines by Committee on Publication Ethics (COPE). Microbes takes the responsibility to enforce a rigorous peer-review together with strict ethical policies and standards to ensure to add high quality scientific works to the field of scholarly publication. Unfortunately, cases of plagiarism, data falsification, inappropriate authorship credit, and the like, do arise. Microbes takes such publishing ethics issues very seriously and our editors are trained to proceed in such cases with a zero tolerance policy. To verify the originality of content submitted to our journals, we use iThenticate to check submissions against previous publications. Microbes works with PUBLONS to provide reviewers with credit for their work.
Latest News on Microbes
Probiotic delivers anticancer drug to the gut | |
| Researchers shrink gastrointestinal tumors in mice using a yeast probiotic to deliver immunotherapy to the gut, offering a potentially novel strategy to target hard-to-reach gut cancers. | |
| Posted: 2024-11-20 | More... |
Building roots in glass, a bio-inspired approach to creating 3D microvascular networks using plants and fungi | |
| Researchers have developed a new bio-inspired approach to building complex 3D microfluidic networks by utilizing plant roots and fungal hyphae as molds. The team grew plants and fungi in nanoparticles of silica, then baked out the plants and solidified the glass. What remains is glass with micrometer-sized networks where the roots used to be. | |
| Posted: 2024-11-19 | More... |
Eradivir's EV25 therapeutic reduces advanced-stage influenza viral loads faster, more thoroughly in preclinical studies than current therapies | |
| A research article shows that Eradivir's patent-pending antiviral therapeutic called EV25 reduces lung viral loads of advanced-stage influenza in preclinical studies quicker and more effectively than currently available therapies. | |
| Posted: 2024-11-19 | More... |
Researchers use biophysics to design new vaccines against RSV and related respiratory viruses | |
| In most people, the lung-infecting pathogens known as respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) trigger mild cold-like symptoms. But in infants and seniors, these viruses can cause severe pneumonia and even death. Vaccines against both viruses, however, have been difficult to design. Now, scientists have analyzed the structure and stability of a critical RSV and hMPV protein to better design vaccines that target it. | |
| Posted: 2024-11-19 | More... |
New nasal vaccine shows promise in curbing whooping cough spread | |
| A new nasal whooping cough vaccine showed an ability to prevent both infection and transmission of the disease in mice. Current vaccines offer treatment but fail to halt transmission of the bacteria that cause the disease. | |
| Posted: 2024-11-18 | More... |
